Related Experiment Video
Updated: Apr 28, 2026

Improving IV Insulin Administration in a Community Hospital
Published on: June 11, 2012
Glycemic variability and outcome in critically ill
Subhash Todi1, Mahuya Bhattacharya1
1Department of Critical Care Medicine, AMRI Hospitals, Kolkata, West Bengal, India.
Insights
High glucose variability (GV) is linked to increased intensive care unit (ICU) mortality. This association is significant even for patients with blood glucose levels in the normal range, highlighting GV as a critical prognostic indicator.
Area of Science:
- Critical Care Medicine
- Endocrinology
- Clinical Pathology
Background:
- Glycemic control encompasses acute hyperglycemia, hypoglycemia, and glycemic variability (GV), all impacting patient outcomes.
- Glycemic variability may confound results in tight glycemic control trials.
Purpose of the Study:
- To investigate the relationship between glycemic variability and intensive care unit (ICU) mortality within the Indian population.
- To assess GV as a prognostic marker in critically ill patients.
Main Methods:
- Retrospective analysis of a prospectively collected database.
- Inclusion of adult patients from Medical, Surgical, Trauma, and Neuro ICUs at a tertiary care hospital.
- Analysis of patients with at least four blood glucose measurements during their ICU stay.
Main Results:
- A cohort of 2208 patients with 11,335 blood glucose values was analyzed.
- Both standard deviation (SD) and glycemic lability index (GLI) of blood glucose were significantly associated with increased ICU mortality (P < 0.001).
- Elevated GV correlated with higher mortality, particularly in patients with blood glucose levels within the euglycemic range.
Conclusions:
- Increased glycemic variability is a significant predictor of higher ICU mortality in a diverse group of critically ill patients.
- The prognostic impact of GV is pronounced even when blood glucose levels are within the euglycemic range.
Background:
Acute hyperglycemia, hypoglycemia and glycemic variability (GV) have been found to be the three principal domains of glycemic control, which can adversely affect patient outcome. GV may be the confounding factor in tight glycemic control trials in surgical and medical patient.
Objective:
This study was conducted to establish if there was any relationship between GV and intensive care unit (ICU) mortality in the Indian context.
Study Design:
A retrospective review of a large cohort of prospectively collected database.
Setting:
Adult Medical/Surgical/Trauma/Neuro ICU of a tertiary care hospital.
Patient Population:
All patients who had four or more blood glucose measured during the ICU stay.
Outcome:
ICU mortality.
Result:
2208 patients with a total of 11,335 blood glucose values were analyzed. GV measured by the standard deviation (SD) of mean blood glucose and glycemic lability index (GLI), both were significantly (P < 0.001) associated with ICU mortality. This relationship was maintained (odds ratio (OR): 2.023, 95% confidence interval (CI): 1.483-2.758) even after excluding patients with hypoglycemia (<60 mg/dl). Patients with blood glucose values in the euglycemic range but highest SD had higher mortality (54%) compared to mortality (24%) in patients above the euglycemic range. Similarly patients with blood sugar values below the average for study cohort and high GLI, another marker of GV had higher mortality (OR: 5.62, CI: 3.865-8.198) than compared to patients in the hyperglycemic range, reflecting the importance of GV as a prognostic marker in patients with blood sugar in the euglycemic range.
Conclusion:
This study demonstrated that high glucose variability is associated with increased ICU mortality in a large heterogeneous cohort of ICU patients. This effect was particularly evident among patients in the euglycemic range.
More Related Videos
07:22Glycemic Impact on Knee Osteoarthritis Symptoms on Physical, Radiographic, and Inflammatory Markers among Individuals Aged 50 and Over with Diabetes
Published on: March 7, 2025
06:59Characterization of Metabolic Status in Nonhuman Primates with the Intravenous Glucose Tolerance Test
Published on: November 13, 2016
Related Concept Videos
Hyperglycemia
Hypoglycemia and Glucagon
Diabetic Ketoacidosis ll: Pathophysiology
Overview of Carbohydrate Metabolism
Glucose transport into cells is facilitated by a family of transport proteins called GLUT (Glucose Transporters). GLUT4 is the primary glucose transporter for insulin-stimulated glucose...
Diabetes Mellitus: Type 2 and Gestational
SBAR II: Application of SBAR
SBAR Report from a Nurse to a Health Care Provider
S: "Hello, Dr. Smith. This is Jane, RN, from the Med Surg unit. I am calling to tell you about Ms. White in Room 210, who is experiencing increased pain and redness at her incision site. Her recent...